Cell Sourcing: Apheresis Collections For R&D And cGMP

The advanced therapy industry faces unique challenges due to the evolving regulatory landscape and specific storage and distribution conditions necessary to maintain product safety and quality. A reliable source of high-quality starting material to meet the needs of both R&D and cGMP applications is critical for a flexible, robust cell therapy program.

Learn how a cell sourcing partner that leverages a large, diverse donor pool and utilizes reliable collection, processing, manufacturing, and cryopreservation methods is key for producing fully characterized starting material that meets the highest standards.